BC-3781 Study Center 012 — Columbus, Georgia

BC-3781 Study Center 012 is a clinical research site located in Columbus, Georgia, United States 31904.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

BC-3781 Study Center 012 has participated in 1 clinical trials.

Therapeutic areas: Bacterial Infections, Infection.

Sponsors: Nabriva Therapeutics AG.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Columbus

Browse all research sites in Georgia · View every site in Columbus

• Columbus Regional Hospital
• Clincept - Veterans Pkwy.
• St Francis Hospital
• Piedmont Columbus Regional-Midtown Hospital
• Fort Benning - Martin Army Community Hospital
• The Hughston Clinic, P.C., Hughston Hospital and Rehabilitation Center
• John B Amos Cancer Center
• Columbus Regional Research Institute
• Research Site
• GSK Investigational Site
• Medical Center/John B. Amos Community Cancer Center
• Centricity Research

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for BC-3781 Study Center 012?

BC-3781 Study Center 012 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has BC-3781 Study Center 012 conducted?

BC-3781 Study Center 012 has 1 clinical trials on record. Their work covers Bacterial Infections, Infection.

Is BC-3781 Study Center 012 accredited by Crixeo Clinical Trials?

BC-3781 Study Center 012 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about BC-3781 Study Center 012?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.